Best Adenocarcinoma doctors in Israel: TOP 21 doctors

Dr. Pelles Sharon specializes in advanced adenocarcinoma treatments at Sourasky Medical Center, including HIPEC and immunotherapy.

• Expert in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for abdominal cancers
• Provides personalized immunotherapy protocols including Keytruda
• Conducts clinical research on patient attitudes toward cancer trials
• Performs complex Whipple procedures for pancreatic adenocarcinoma

Head of the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – Dr. Merimsky specializes in complex sarcoma cases.

• Over 41 years of experience of experience in orthopedic oncology
• Fellowship-trained at Institut Gustave Roussy in Paris
• Member of ESMO Sarcoma Faculty and IASLC
• Published extensively on bone and soft tissue malignancies

Dr. Sarid specializes in chemotherapy and radiotherapy with over 38 years of experience of oncology experience at Israel's leading Sourasky (Ichilov) Medical Center.

• Educated at Oxford University in cancer urology
• Principal investigator for clinical trials in cancer therapies
• Authored 30+ articles on cancer treatment
• Member of ESMO, ASCO, and Israeli oncology societies

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.

She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.

Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Professor Ido Wolf heads the medical oncology department at Tel Aviv's top Sourasky Medical Center and provides consultations for second opinions.

• Specializes in providing second opinions in medical consultations
• Extensive training at Sheba Medical Center and Cedars-Sinai Medical Center
• Holds a PhD and an academic teaching role at Tel Aviv University
• Memberships include ASCO, AACR and other major international oncology organizations

Dr. Raphael leads Israel's national genomic medicine initiative for oncology and pioneers clinical trials in NSCLC immunotherapy.

• Senior lecturer at Tel Aviv University's Faculty of Medical Sciences
• Principal investigator for multiple NSCLC immunotherapy trials
• Moderator of Israel's Lung Cancer Society Molecular Tumor Board
• Specializes in genomic profiling and liquid biopsy techniques
• Recipient of ESMO and IASLC memberships

Director of oncology hospitalization at Ichilov, one of Israel's top hospitals, and involved in cutting-edge clinical trials since 2005.

• Over 26 years of experience of clinical experience in oncology and internal medicine
• Conducts primary and secondary research in phase I, II, and III oncology studies
• Licensed to practice medicine in Israel since January 2000
• Trained in oncology through a dedicated internship at Tel Aviv Medical Center

Heads the Colorectal Surgery Department at Sourasky Medical Center (Ichilov) – an authority in open and minimally invasive techniques.

• Over 35 years of experience of surgical experience
• Top specialist in performing the complex Whipple procedure
• Abdominal surgeon focused specifically on cancer surgery

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Karen Drumea is a Radiotherapy Specialist and Oncologist at Rambam Medical Center, focusing on precise and effective treatment plans.

• Specializes in radiotherapy for adenocarcinoma
• Works at Rambam Medical Center, a leading healthcare institution
• Dedicated to personalized patient care

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Zalmanova specializes in radiotherapy with a focus on adenocarcinoma at Assuta Medical Center.

• Radiotherapist with expertise in targeted radiation treatments
• Works at Assuta Medical Center, known for advanced oncology care
• Focuses on personalized treatment plans for adenocarcinoma patients

Leads the entire Oncology Center as its Chief Physician at Assuta Medical Center.

• Specializes in medical oncology and cancer treatment
• Extensive experience managing complex cancer cases
• Oversees a leading oncology department's patient care and protocols